Learning ObjectivesAt the end of the module, delegates would be expected:to be aware of the issues of drug treatments and the developing brain;to be updated on recent advances in the drug treatment of psychoses in children and adolescents;to be aware of the advances in understanding the neurobiology of depression in young people and the role of SSRIs and other new antidepressants;to be updated on the use of drugs in the treament of Tourette’s syndrome and OCD in children and adolescents;to have the opportunity to raise questions with a panel of experts;to have the opportunity to join practical workshops on prescribing;to learn how to critically appraise the evidence for drug treatments in children and adolescentsThis module is eligible for 10 CPD hours which are subject to peer group review.